New drug offers hope for new moms with severe depression
NCT ID NCT02942004
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tested an experimental drug called SAGE-547 in 138 women with severe postpartum depression. The drug was given as a 60-hour IV infusion to see if it could quickly reduce depression symptoms compared to a placebo. The goal was to help new mothers feel better without long-term medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sage Investigational Site
Chandler, Arizona, 85226, United States
-
Sage Investigational Site
Rogers, Arkansas, 72758, United States
-
Sage Investigational Site
Lemon Grove, California, 91945, United States
-
Sage Investigational Site
Orange, California, 92868, United States
-
Sage Investigational Site
Ventura, California, 93003, United States
-
Sage Investigational Site
Gainesville, Florida, 32607, United States
-
Sage Investigational Site
Miami, Florida, 33147, United States
-
Sage Investigational Site
Miramar, Florida, 33027, United States
-
Sage Investigational Site
Orlando, Florida, 32807, United States
-
Sage Investigational Site
Pensacola, Florida, 32502, United States
-
Sage Investigational Site
Pinellas Park, Florida, 33782, United States
-
Sage Investigational Site
Atlanta, Georgia, 30331, United States
-
Sage Investigational Site
Hoffman Estates, Illinois, 60169, United States
-
Sage Investigational Site
Wichita, Kansas, 67226, United States
-
Sage Investigational Site
Edgewood, Kentucky, 41017, United States
-
Sage Investigational Site
Owensboro, Kentucky, 42303, United States
-
Sage Investigational Site
Boston, Massachusetts, 02114, United States
-
Sage Investigational Site
Boston, Massachusetts, 02115, United States
-
Sage Investigational Site
Flowood, Mississippi, 39232, United States
-
Sage Investigational Site
Marlton, New Jersey, 08053, United States
-
Sage Investigational Site
Glen Oaks, New York, 11004, United States
-
Sage Investigational Site
Chapel Hill, North Carolina, 27514, United States
-
Sage Investigational Site
Charlotte, North Carolina, 28211, United States
-
Sage Investigational Site
Raleigh, North Carolina, 27612, United States
-
Sage Investigational Site
Columbus, Ohio, 43210, United States
-
Sage Investigational Site
Dayton, Ohio, 45417, United States
-
Sage Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
Sage Investigational Site
Houston, Texas, 77030, United States
-
Sage Investigational Site
Houston, Texas, 77058, United States
-
Sage Investigational Site
Richardson, Texas, 75080, United States
-
Sage Investigational Site
San Antonio, Texas, 78229, United States
-
Sage Investigational Site
Orem, Utah, 84058, United States
Conditions
Explore the condition pages connected to this study.